Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study

Several clinically approved recombinant erythropoietin (rEPO) preparations, such as epoetin-β, epoetin-δ and the epoetin-α derivative, darbepoetin-α, have been commercially produced. Since the expiration of patent protection, a number of novel rEPO biosimilars have been approved on the world market....

Descripción completa

Detalles Bibliográficos
Autores principales: OHTA, SHOICHIRO, YASUNO, NOBUHIRO, INOMOTO, YUKI, MATSUDA, KAORI, NAKAGAWA, YOSHIHIKO, SASAGAWA, ISOJI, TANAKA, MASAHIKO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861354/
https://www.ncbi.nlm.nih.gov/pubmed/24348759
http://dx.doi.org/10.3892/etm.2013.1384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861354/
https://www.ncbi.nlm.nih.gov/pubmed/24348759
http://dx.doi.org/10.3892/etm.2013.1384

Ejemplares similares